Efcure 600 mg (Efavirenz)
| Active Ingredient | Efavirenz |
|---|---|
| Indication: | HIV infection |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging | 30 tablets in 1 bottle |
| Strength | 600mg |
| Delivery Time | 6 To 15 days |
Efcure 600 mg contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretroviral drugs to treat HIV-1 infection. Efavirenz works by directly binding to and inhibiting the reverse transcriptase enzyme, a key component the virus uses to replicate its genetic material. By stopping this process, Efcure helps lower HIV viral load, boost CD4 cell counts, and delay the progression of the disease.
Efavirenz is often part of first-line antiretroviral therapy (ART) and is usually combined with other drugs such as Tenofovir and Emtricitabine for maximum effectiveness.








There are no reviews yet.